Literature DB >> 3204366

Acute and chronic hepatitis delta virus infection: direct or indirect effect on hepatitis B virus replication?

P Farci1, P Karayiannis, M E Lai, F Marongiu, G Orgiana, A Balestrieri, H C Thomas.   

Abstract

In a large population of patients, chronic hepatitis delta virus (HDV) infection was usually associated with absence of hepatitis B virus (HBV) replication. However, acute HDV superinfection progressing to chronic HDV infection in two hepatitis B e antigen (HBeAg)-positive HBV carriers and coinfection in two other patients who progressed to chronic HBV (HBeAg-positive) and HDV infection was associated with continuing high-level HBV replication for several years. Thus HDV infection does not always inhibit HBV replication. The hypothesis that the different effects of HDV coinfection and superinfection on HBV replication may stem from variability in the capacity of the host to produce and respond to interferon is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3204366     DOI: 10.1002/jmv.1890260308

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

Review 1.  Hepatitis D virus coinfection and superinfection.

Authors:  Francesco Negro
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  Clinical presentation and genotype of hepatitis delta in Karachi.

Authors:  Tariq Moatter; Zaigham Abbas; Sabhita Shabir; Wasim Jafri
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

Review 3.  Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management.

Authors:  Ranjit Chauhan; Shilpa Lingala; Chiranjeevi Gadiparthi; Nivedita Lahiri; Smruti R Mohanty; Jian Wu; Tomasz I Michalak; Sanjaya K Satapathy
Journal:  World J Hepatol       Date:  2018-03-27

Review 4.  Hepatitis delta virus: a peculiar virus.

Authors:  Carolina Alves; Cristina Branco; Celso Cunha
Journal:  Adv Virol       Date:  2013-10-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.